Daiichi Sankyo’s takeover of ‘Effient’ license
Daiichi Sankyo Korea(CEO Dae-joon Kim) announced a transfer of the product right of an oral antiplatelet agent, ‘Effient(generic name: prasugrel),’ from Lilly Korea as of the 13th of July.
Daiichi Sankyo Korea and Lilly Korea has jointly promoted Effient in Korea since October 2010, and Daiichi ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
